Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Ross

Showing results (341-350 of 670) with videos related to

Pageof 67
Sort By:
Cancer|April 3, 2008
Prospective assessment of the reliability, validity, and sensitivity to change of the Functional Assessment of Cancer Therapy-Melanoma questionnaireJanice N Cormier, Merrick I Ross, Jeffrey E Gershenwald, et al.
Journal of the American College of Surgeons|March 22, 2003
Surgical decision making and factors determining a diagnosis of breast carcinoma in women presenting with nipple dischargeNeslihan Cabioglu, Kelly K Hunt, S Eva Singletary, et al.
American Journal of Surgery|December 6, 2011
Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thickerGlenda G Callender, Michael E Egger, Alison L Burton, et al.
In Vivo (Athens, Greece)|November 1, 1991
Immunological properties of melanoma tumor-infiltrating lymphocytes before and after IL-2-based biotherapiesK Itoh, C M Balch, J L Murray, et al.
Cancer|October 15, 2010
Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomyMin Yi, Steven J Kronowitz, Funda Meric-Bernstam, et al.
Cancer|April 30, 2008
Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapyJacqueline S Jeruss, Lisa A Newman, Gregory D Ayers, et al.
Annals of Surgical Oncology|January 5, 2002
Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsyS Dessureault, S J Soong, M I Ross, et al.
Annals of Surgical Oncology|July 4, 2003
Complications associated with sentinel lymph node biopsy for melanomaWilliam R Wrightson, Sandra L Wong, Michael J Edwards, et al.
Cancer|May 7, 2008
How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer?Min Yi, Funda Meric-Bernstam, Merrick I Ross, et al.
Cancer|February 27, 2010
Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysisYan Xing, George J Chang, Chung-Yuan Hu, et al.
Pageof 67

Showing results (341-350 of 670) with videos related to

Sort By:
Pageof 67
Cancer|April 3, 2008
Prospective assessment of the reliability, validity, and sensitivity to change of the Functional Assessment of Cancer Therapy-Melanoma questionnaireJanice N Cormier, Merrick I Ross, Jeffrey E Gershenwald, et al.
Journal of the American College of Surgeons|March 22, 2003
Surgical decision making and factors determining a diagnosis of breast carcinoma in women presenting with nipple dischargeNeslihan Cabioglu, Kelly K Hunt, S Eva Singletary, et al.
American Journal of Surgery|December 6, 2011
Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thickerGlenda G Callender, Michael E Egger, Alison L Burton, et al.
In Vivo (Athens, Greece)|November 1, 1991
Immunological properties of melanoma tumor-infiltrating lymphocytes before and after IL-2-based biotherapiesK Itoh, C M Balch, J L Murray, et al.
Cancer|October 15, 2010
Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomyMin Yi, Steven J Kronowitz, Funda Meric-Bernstam, et al.
Cancer|April 30, 2008
Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapyJacqueline S Jeruss, Lisa A Newman, Gregory D Ayers, et al.
Annals of Surgical Oncology|January 5, 2002
Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsyS Dessureault, S J Soong, M I Ross, et al.
Annals of Surgical Oncology|July 4, 2003
Complications associated with sentinel lymph node biopsy for melanomaWilliam R Wrightson, Sandra L Wong, Michael J Edwards, et al.
Cancer|May 7, 2008
How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer?Min Yi, Funda Meric-Bernstam, Merrick I Ross, et al.
Cancer|February 27, 2010
Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysisYan Xing, George J Chang, Chung-Yuan Hu, et al.
Pageof 67